Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
European Medicines Agency in Amsterdam seeks a motivated Seconded National Expert to join the H-TA department and contribute to vaccine science in the area of NCD indications. This role involves assessing vaccine applications and advising EU bodies on scientific and regulatory aspects.
You will support the evaluation of vaccines for NCD indications, help shape policy development, and ensure high-quality scientific outputs through collaboration with committees and stakeholders.
Select how often (in days) to receive an alert:
Type of position: Seconded National Expert
Reference:EMA/SNE/11660
Job title:SNE/Scientific Specialist (Vaccinology, immunology and inflammation)
Deadline for applications:06 December 2026 at 23.59 CET
The European Medicines Agency is a decentralized body of the European Union with all its offices and Headquarters based in Amsterdam, the Netherlands.Its core responsibility is the protection and promotion of public health through the evaluation and supervision of medicines.
We are looking for National experts on secondment. This means staff from other European public-sector bodies can work at the European Medicines Agency (EMA) for short periods of time through the national expert on secondment (SNE) programme. The aim of this programme is to enhance and develop the relationship between European public administrations.
SNEs serve a dual role: they bring their expertise to EMA and take back to their home administration the knowledge acquired during their period of secondment. SNEs remain in the service of their employer. Secondment is not equivalent to employment, nor does it lead to employment by EMA.Periods of secondment may lastbetween six months and two years. This is renewable once or more,up to a total of four years.
This announcement is governed by theRules governing the secondment of national experts. For further information please visit our Careers portal.
The European Medicines Agency (EMA) is seeking a motivated Seconded National Expert (SNE) to join the H-TA department and contribute to an evolving area of vaccine science. As research into the potential impact of vaccination on non-communicable diseases (NCDs) expands, interest in scientific advice and in seeking NCD indications for vaccines is growing. This role offers an exciting opportunity to work at the forefront of scientific and regulatory developments, bringing your expertise in vaccinology, immunology and inflammation to the evaluation of vaccines for NCDs.
In this role, you will contribute to the assessment of applications for vaccines seeking an NCD indication in the EU, advise the Agency and its scientific committees, and help shape policy development, including scientific guidelines. Your specialist knowledge will support scientific assessment and the development of regulatory approaches in this emerging field.
Act as an expert in vaccinology, immunology and inflammation; performing the following tasks:
Education
Field of Study
Medicine or Life Science (e.g. biology, chemistry, biochemistry, pharmacy).
Experience
Experience in either a competent authority in the field of medicines regulation, the pharmaceutical industry or in a healthcare / academic setting should have been obtained in the scientific, regulatory, or procedural aspects of the research, development, authorisation, production s or supervision of human medicines
Skills & Knowledge
Critical review and drafting of scientific and regulatory documents for expert and lay audiences;
Presenting scientific, or regulatory matters at a high level (including experts);
Knowledge and understanding of the EU pharmaceutical legislation and the regulatory framework for pharmaceutical products in the EU;
Knowledge of the typical issues in quality, non-clinical, or clinical development in one or more therapeutic areas;
Knowledge of general methodology for quality, non-clinical, or clinical development;
Knowledge of at least one area relevant for quality, non-clinical, or clinical development of medicines.
Experience
Timelines
Deadline for applications 06 December 2026 at 23:59 CET
Interviews From 11 January 2027
Decision expected From February 2027
Process
This post is published in line with Chapter II Art 4 of EMA/329753/2015 (European Medicines Agency Decision of 30 June 2015 laying down general implementing provisions on the procedure governing the engagement and use of temporary staff under Article 2(f) of the Conditions of Employment of Other Servants of the European Union).
The process will follow Annex I of Guidance on Internal Talent Marketplace.
Only eligible candidates (see eligibility criteria (i.e. temporary staff 2(f) who, on the closing date for applications and on the day of filling the post, are engaged within the agency in the function group and grade belonging to the grade bracket indicated in the internal publication.) will be assessed further.
The assessment of qualifications and suitability will be based solely on the required competencies, skills, knowledge, qualifications and experience for the role as stated in the internal publication.
Shortlisting
Talent Acquisition may publish additional pre-screening questions but, normally, the initial assessment will be conducted based on the application form submitted for an opening, and all eligible staff will be invited for a follow up assessment
Assessments
The assessments will include at the very least interviews and, only in specific circumstances, a written test, to identify the most suitable candidate.
In case of Head of Service roles, personality assessment or assessment of managerial competencies via assessment centre will be conducted.
Job offers
This publication is intended to fill a specific vacancy(ies), therefore, as a result of the assessments, the Selection Committee will recommend to the Executive Director the best candidate for the appointment, plus it may recommend 2-3 alternates from among those were found qualified and suitable for the specific vacancy in question. An additional interview with the hiring entity may be arranged before the final decision to recruit the candidate. Alternate candidates may be offered a position in case the initially selected candidate cannot take up the offer or their employment is not confirmed after probation period, but they are not placed in any reserve list. Alternate candidates may be appointed to other similar vacant post based on Art 7 of Staff Regulations.
The selected candidate, as well as all alternates, will be informed accordingly of the result of the internal publication.
Conditions of employment
The selected member of temporary staff 2(f) shall be assigned to the new post by written decision of the Executive Director without impact on his/her current contract of employment with the agency.
______________________________________________________________________________________________________
Domenico Scarlattilaan 6 - 1083 HS Amsterdam - The Netherlands
Telephone +31 (0)88 781 6000 - Email recruitment@ema.europa.eu
Serving a population of 500 million citizens, we promote and protect public animal health in EU Member States, as well as the countries of the European Economic Area, by ensuring that all medicines available on the EU market are safe, effective and of high quality.
Job Segment: Pharmaceutical, Chemistry, Recruiting, Temporary, Pharmacy, Science, Human Resources, Contract, Healthcare